Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02719847 · ClinicalTrials.gov registry record
EBUS TBNA After PET/CT in Diagnosing Patients With Stage I-IIA Non-small Cell Lung Cancer Evaluated for Stereotactic Body Radiation Therapy
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 150
- Enrollment target
NCT02719847: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT02719847 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02719847 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
This clinical trial studies how well endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) after positron emission tomography/computed tomography (PET/CT) scan works in diagnosing patients with stage I-IIA non-small cell lung cancer evaluated for stereotactic body radiation therapy (SBRT). Performing EBUS-TBNA after PET/CT scan may help doctors learn more about the accuracy and ways to find early stage lung cancer.
Interventions
- PROCEDURE Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2016-03-18 |
| Est. Completion | 2025-09-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02719847
The ClinicalTrials.gov registry entry for NCT02719847 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is the first listed.
NCT02719847 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02719847 about?
NCT02719847 is a clinical study titled "EBUS TBNA After PET/CT in Diagnosing Patients With Stage I-IIA Non-small Cell Lung Cancer Evaluated for Stereotactic Body Radiation Therapy". This clinical trial studies how well endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) after positron emission tomography/computed tomography (PET/CT) scan works in diagnosing patients with stage I-IIA non-small cell lung cancer evaluated for stereotactic body radiation th...
What is the current status of trial NCT02719847?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2016-03-18. Estimated completion is 2025-09-12.
What interventions are being tested in trial NCT02719847?
The interventions under investigation include: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) (PROCEDURE).
Who is sponsoring clinical trial NCT02719847?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.